Ultrastructural mitochondrial alterations in Equine myopathies of unknown origin

References

• Aleman M. 2008. A review of equine muscle disorders. Neuromuscul Disord. 18:277–287.
   PubMed Web of Science ®Google Scholar
• Aleman M, Watson JL, Williams DC, LeCouteur RA, Nieto JE, Shelton GD. 2006. Myopathy in horses with pars intermedia dysfunction (Cushing's disease). Neuromuscul Disord. 16:737–744.
   PubMed Web of Science ®Google Scholar
• Bourgeois JM, Tarnopolsky MA. 2004. Pathology of skeletal muscle in mitochondrial disorders. Mitochondrion. 4:441–452.
   PubMed Web of Science ®Google Scholar
• Brown WM, George M Jr, Wilson AC. 1979. Rapid evolution of animal mitochondrial DNA. Proc Natl Acad Sci USA. 76:1967–1971.
   PubMed Web of Science ®Google Scholar
• Cassart D, Baise E, Cherel Y, Delguste C, Antoine N, Votion D, Amory H, Rollin F, Linden A, Desmecht D. 2007. Morphological alterations in oxidative muscles and mitochondrial structure associated with equine atypical myopathy. Equine Vet J. 39:26–32.
   PubMed Web of Science ®Google Scholar
• Chen H, Vermulst M, Wang Y, Chomyn A, Prolla T, McCaffery J, Chan D. 2010. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell. 141:280–289.
   PubMed Web of Science ®Google Scholar
• Cheville FN. 1994. Ultrastructural pathology: an introduction to interpretation. Ames (IA): Iowa State University Press. Chapter 2, Interpretation of acute cell injury: degeneration; p. 51–76.
   Google Scholar
• Detmer S, Chan D. 2007. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol. 8:870–879.
   PubMed Web of Science ®Google Scholar
• De Vivo DC, Dimauro S. 1990. Mitochondrial defects of brain and muscle. Biol Neonate. 58:54–69.
   PubMedGoogle Scholar
• Dimauro S, Davidzon G. 2005. Mitochondrial DNA and disease. Ann Med. 37:222–232.
   PubMed Web of Science ®Google Scholar
• Gomes LC, Di Benedetto G, Scorrano L. 2011. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol. 13:589–598.
   PubMed Web of Science ®Google Scholar
• Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, Wong LJ, Cohen BH, Naviaux RK. 2008. The in-depth evaluation of suspected mitochondrial disease. Mol Gen Metab. 1:16–37.
   Web of Science ®Google Scholar
• Harrison S, Turrion-Gomez J. 2006. Mitochondrial DNA: an important female contribution to thoroughbred racehorse performance. Mitochondrion 6:53–66.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Wei Y, Huang Y, Jiang H, Guo Y, Lan G, Liao, DJ. 2011. The complete mitochondrial genome and phylogenetic analysis of the Debao pony (Equus Caballus). Mol Biol Rep. 38:593–599.
   PubMed Web of Science ®Google Scholar
• Kanzaki Y, Terasaki F, Okabe M, Otsuka K, Katashima T, Fujita S, Takahide I, Kitaura Y. 2010. Giant mitochondria in the myocardium of a patient with mitochondrial cardiomyopathy, transmission and 3-dimensional scanning electron microscopy. Circulation. 121:831–832.
   PubMed Web of Science ®Google Scholar
• Koshiba T, Detmer S, Kaiser J, Chen H, McCaffery J, Chan D. 2004. Structural basis of mitochondrial tethering by mitofusin complexes. Science. 305:858–862.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi S, Nishino I. 2013. Megaconial congenital muscular dystrophy due to loss-of-function mutations in choline kinase beta. Curr Opin Neurol. 26:536–543.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Shaw J. 2005. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Ann Rev Genet. 39:503–536.
   PubMed Web of Science ®Google Scholar
• Pfeffer G, Chinnery PF. 2013. Diagnosis and treatment of mitochondrial myopathies. Ann Med. 45:4–16.
   PubMed Web of Science ®Google Scholar
• Rifai Z, Welle S, Kamp C, Thornton CA. 1995. Ragged red fibers in normal aging and inflammatory myopathy. Ann Neurol. 37:24–29.
   PubMed Web of Science ®Google Scholar
• Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. 2004. The epidemiology of mitochondrial disorders-past, present and future. Biochim Biophys Acta. 1659:115–120.
   PubMed Web of Science ®Google Scholar
• Son Z, Ghochani M, McCaffery J, Frey T, Chan D. 2009. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Molec Biol Cell. 20:3525–3532.
   PubMed Web of Science ®Google Scholar
• Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. 2004. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord. 14:237–245.
   PubMed Web of Science ®Google Scholar
• Valberg SJ, Carlson GP, Cardinet GH, Birks EK, Jones JH, Chomyn A, DiMauro S. 1994. Skeletal muscle mitochondrial myopathy as a cause of exercise intolerance in a horse. Muscle Nerve. 17:305–312.
   PubMed Web of Science ®Google Scholar
• Van Galen G, Saegerman C, Pitel CM, Patarin F, Amory H, Baily JD, Cassart D, Gerber V, Hahn C, Harris P, et al. 2012. European outbreaks of atypical myopathy in grazing horses (2006–2009): determination of indicators for risk and prognostic factors. Equine Vet J. 44:621–625.
   PubMed Web of Science ®Google Scholar
• Westermann B. 2010. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol. 11:872–884.
   PubMed Web of Science ®Google Scholar
• Westermann CM, Dorland L, van Diggelen OP, Schoonderwoerd K, Bierau J, Waterham HR, van der Kolk JH. 2011. Decreased oxidative phosphorylation and PGAM deficiency in horses suffering from atypical myopathy associated with acquired MADD. Mol Genet Metab. 104:273–278.
   PubMed Web of Science ®Google Scholar